Short-Course Selinexor and Decitabine With Homoharringtonine-Based Chemotherapy for Pretransplant Cytoreduction in TP53-Altered Complex-Karyotype Myeloid Neoplasms.
- DOI
- 10.1002/hon.70276
- Published
- 2026 Nov
- Container
- Hematological oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hon.70276,
title = {Short-Course Selinexor and Decitabine With Homoharringtonine-Based Chemotherapy for Pretransplant Cytoreduction in TP53-Altered Complex-Karyotype Myeloid Neoplasms.},
author = {Zhang A and Cui Q and Li M and Yu Y and Liu S and Chen X and Pan J and Shen H and Wu D and Tang X},
year = {2026},
journal = {Hematological oncology},
doi = {10.1002/hon.70276},
url = {https://doi.org/10.1002/hon.70276}
}RIS
TY - JOUR TI - Short-Course Selinexor and Decitabine With Homoharringtonine-Based Chemotherapy for Pretransplant Cytoreduction in TP53-Altered Complex-Karyotype Myeloid Neoplasms. AU - Zhang A AU - Cui Q AU - Li M AU - Yu Y AU - Liu S AU - Chen X AU - Pan J AU - Shen H AU - Wu D AU - Tang X PY - 2026 JO - Hematological oncology DO - 10.1002/hon.70276 UR - https://doi.org/10.1002/hon.70276 ER -
APA
A, Z., Q, C., M, L., Y, Y., S, L., X, C., J, P., H, S., D, W., & X, T. (2026). Short-Course Selinexor and Decitabine With Homoharringtonine-Based Chemotherapy for Pretransplant Cytoreduction in TP53-Altered Complex-Karyotype Myeloid Neoplasms.. Hematological oncology. https://doi.org/10.1002/hon.70276
Source records
- pubmed · retrieved 2026-11-10T05:43:08.497Z